DiaMedica Therapeutics Announces 2024 Financial Results and Business Update
March 17, 2025 - 23:55
MINNEAPOLIS, March 17, 2025—DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for acute ischemic stroke and preeclampsia, has released its financial results for the year ending December 31, 2024. The company outlined its strategic initiatives and progress made over the past year, highlighting advancements in their clinical programs.
With a focus on addressing significant unmet medical needs, DiaMedica has made strides in its research efforts, particularly in the areas of acute ischemic stroke and preeclampsia. The company is committed to advancing its pipeline and believes that its innovative therapies have the potential to transform patient outcomes.
To further discuss these developments and the financial results, management will conduct a conference call on Tuesday, March 18, 2025, at 8:00 AM Eastern Time. This call will provide an opportunity for stakeholders to gain insights into the company’s future plans and ongoing projects.
MORE NEWS
July 19, 2025 - 03:18
Inside Northrop Grumman's Semiconductor ProductionMax Gorden recently had the opportunity to explore Northrop Grumman`s semiconductor microchip production facility, shedding light on the critical role these components play in modern technology. As...
July 18, 2025 - 01:31
Legalizing Cannabis: A Path for Small Businesses in Pennsylvania?As a heavily regulated industry, any cannabis bill ultimately signed into law could significantly shape the business landscape in Pennsylvania and determine who stands to benefit from it. Advocates...
July 17, 2025 - 11:39
Remembering Bob Funk Sr.: A Pillar of Oklahoma's Business and Agricultural LandscapeBob Funk Sr., a prominent entrepreneur and cattleman, passed away at his Yukon home, leaving a lasting impact on Oklahoma`s business and agricultural communities. Known for his visionary leadership...
July 16, 2025 - 17:34
NYC Business Leaders Voice Opposition to Mayoral Candidate's PoliciesIn a recent discussion, prominent New York business figures, including former Douglas Elliman CEO Dottie Herman and Stew Leonard’s President and CEO Stew Leonard Jr., expressed their concerns...